Clinical Trial Update: ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber [NA]

View source ↗

Summary

The ASSET trial evaluating the Alteco LPS adsorber for septic shock has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Alteco LPS Adsorber

Snippet

Sponsor: Alteco Medical AB | Conditions: Septic Shock | NA | Status: TERMINATED